Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
ATMI Inc. (NASDAQ: ATMI) shares closed up 25.47 percent on Tuesday and hit a new 52-week high of $33.84 during intra-day trading. The stock traded nearly 19 million shares and was one of the biggest gainers on the NASDAQ. Entegris announced Tuesday it would pay $1.15 billion for ATMI. The valuation equates to $850 million when backing out ATMI's cash, which includes $170 million in expected proceeds from the pending sale of the target's life sciences business to Pall.
Get more information on ATMI Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/ATMI
Lionbridge Technologies Inc. (NASDAQ: LIOX) shares closed up 29.43 percent on Tuesday with nearly 4 million shares traded. The stock was one of the biggest gainers in the NASDAQ and hit a new 52-week high of $7.09 during intra-day trading. The company released financial results for the fourth quarter and year ended December 31, 2013. Record revenue of $127.5 million, an increase of $13.6 million, or 12% year-on-year compared to the fourth quarter of 2012.
Get more information on Lionbridge Technologies Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/LIOX
Terra Tech Corp. (OTC: TRTC) shares closed up 35.40 percent on Tuesday with about 10.8 million shares traded. The stock was one of the biggest gainers in the OTC market and hit a new 52-week high of $0.81 during intra-day trading. Inergetics, Inc., a leading developer of nutritional supplements, announced it has entered into a strategic partnership with Terra Tech Corp to jointly develop a line of natural Cannibidiol based nutritional supplements.
Get more information on Terra Tech Corp. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/TRTC
Enzo Biochem Inc. (NYSE: ENZ) shares closed up 17.45 percent on Tuesday with about 1.2 million shares traded. The stock was one of the biggest gainers in the NYSE though the company had no significant news. Enzo Biochem, Inc., an integrated life sciences and biotechnology company, is engaged in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology.
Get more information on Enzo Biochem Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/ENZ
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.